Cargando…

Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers

The use of biomarkers to measure immune responses in serum is crucial for understanding population-level exposure and susceptibility to human pathogens. Advances in sample collection, multiplex testing, and computational modeling are transforming serosurveillance into a powerful tool for public heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiens, Kirsten E., Jauregui, Barbara, Arnold, Benjamin F., Banke, Kathryn, Wade, Djibril, Hayford, Kyla, Costero-Saint Denis, Adriana, Hall, Robert H., Salje, Henrik, Rodriguez-Barraquer, Isabel, Azman, Andrew S., Vernet, Guy, Leung, Daniel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536637/
https://www.ncbi.nlm.nih.gov/pubmed/36201428
http://dx.doi.org/10.1371/journal.pntd.0010657
_version_ 1784803024399499264
author Wiens, Kirsten E.
Jauregui, Barbara
Arnold, Benjamin F.
Banke, Kathryn
Wade, Djibril
Hayford, Kyla
Costero-Saint Denis, Adriana
Hall, Robert H.
Salje, Henrik
Rodriguez-Barraquer, Isabel
Azman, Andrew S.
Vernet, Guy
Leung, Daniel T.
author_facet Wiens, Kirsten E.
Jauregui, Barbara
Arnold, Benjamin F.
Banke, Kathryn
Wade, Djibril
Hayford, Kyla
Costero-Saint Denis, Adriana
Hall, Robert H.
Salje, Henrik
Rodriguez-Barraquer, Isabel
Azman, Andrew S.
Vernet, Guy
Leung, Daniel T.
author_sort Wiens, Kirsten E.
collection PubMed
description The use of biomarkers to measure immune responses in serum is crucial for understanding population-level exposure and susceptibility to human pathogens. Advances in sample collection, multiplex testing, and computational modeling are transforming serosurveillance into a powerful tool for public health program design and response to infectious threats. In July 2018, 70 scientists from 16 countries met to perform a landscape analysis of approaches that support an integrated serosurveillance platform, including the consideration of issues for successful implementation. Here, we summarize the group’s insights and proposed roadmap for implementation, including objectives, technical requirements, ethical issues, logistical considerations, and monitoring and evaluation.
format Online
Article
Text
id pubmed-9536637
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95366372022-10-07 Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers Wiens, Kirsten E. Jauregui, Barbara Arnold, Benjamin F. Banke, Kathryn Wade, Djibril Hayford, Kyla Costero-Saint Denis, Adriana Hall, Robert H. Salje, Henrik Rodriguez-Barraquer, Isabel Azman, Andrew S. Vernet, Guy Leung, Daniel T. PLoS Negl Trop Dis Policy Platform The use of biomarkers to measure immune responses in serum is crucial for understanding population-level exposure and susceptibility to human pathogens. Advances in sample collection, multiplex testing, and computational modeling are transforming serosurveillance into a powerful tool for public health program design and response to infectious threats. In July 2018, 70 scientists from 16 countries met to perform a landscape analysis of approaches that support an integrated serosurveillance platform, including the consideration of issues for successful implementation. Here, we summarize the group’s insights and proposed roadmap for implementation, including objectives, technical requirements, ethical issues, logistical considerations, and monitoring and evaluation. Public Library of Science 2022-10-06 /pmc/articles/PMC9536637/ /pubmed/36201428 http://dx.doi.org/10.1371/journal.pntd.0010657 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Policy Platform
Wiens, Kirsten E.
Jauregui, Barbara
Arnold, Benjamin F.
Banke, Kathryn
Wade, Djibril
Hayford, Kyla
Costero-Saint Denis, Adriana
Hall, Robert H.
Salje, Henrik
Rodriguez-Barraquer, Isabel
Azman, Andrew S.
Vernet, Guy
Leung, Daniel T.
Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title_full Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title_fullStr Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title_full_unstemmed Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title_short Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers
title_sort building an integrated serosurveillance platform to inform public health interventions: insights from an experts’ meeting on serum biomarkers
topic Policy Platform
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536637/
https://www.ncbi.nlm.nih.gov/pubmed/36201428
http://dx.doi.org/10.1371/journal.pntd.0010657
work_keys_str_mv AT wienskirstene buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT jaureguibarbara buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT arnoldbenjaminf buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT bankekathryn buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT wadedjibril buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT hayfordkyla buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT costerosaintdenisadriana buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT hallroberth buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT saljehenrik buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT rodriguezbarraquerisabel buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT azmanandrews buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT vernetguy buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT leungdanielt buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers
AT buildinganintegratedserosurveillanceplatformtoinformpublichealthinterventionsinsightsfromanexpertsmeetingonserumbiomarkers